Introduction: Atherosclerosis as inflammation: A controversial concept becomes accepted

Journal of Internal Medicine

Volumn 263, Issue 5, 2008, Pages 462-463

  Hansson, G K ^a   Nilsson, J ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; IMMUNE RESPONSE; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; THROMBOSIS; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION MEDIATORS; MICE; TH1 CELLS; THROMBOSIS; VASCULITIS;

EID: 42149158984     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01959.x     Document Type: Conference Paper

References (8)

1. Nilsson J, Hansson GK. Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med 2008 263 : 464 78.
2. Chou M-Y, Hartvigsen K, Hansen LF et al. Oxidation-specific epitopes are important targets of innate immunity. J Intern Med 2008 263 : 479 88.
3. Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 2008 263 : 489 99.
4. Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008 263 : 517 27.
5. Wang M, Song W-L, Cheng Y, FitzGerald G. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med 2008 263 : 500 05.
6. Thim T, Hagensen MK, Bentzon JF, Falk E. From vulnerable plaque to atherothrombosis. J Intern Med 2008 263 : 506 16.
7. Leroyer AS, Tedgui A, Boulanger CM. Role of microparticles in atherothrombosis. J Intern Med 2008 263 : 528 37.
8. Hamsten A, Eriksson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Intern Med 2008 263 : 538 52.